Related Experiment Video
Updated: Jun 22, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
[Immunochemical studies of salivary lactoferrin]
Insights
Salivary lactoferrin (LF) levels, measured non-invasively, were elevated in patients with respiratory, digestive diseases, and diabetes. This immunochemical assay shows promise for health screening and monitoring.
Area of Science:
- Biochemistry
- Immunology
- Clinical Diagnostics
Context:
- Saliva is an accessible biofluid for non-invasive diagnostics.
- Lactoferrin (LF) is an iron-binding glycoprotein with antimicrobial and immunomodulatory properties.
- Elevated LF levels may indicate underlying inflammatory or disease states.
Purpose:
- To investigate salivary lactoferrin (LF) levels in a large cohort of patients and healthy individuals.
- To determine the association between salivary LF concentrations and specific diseases, including respiratory and digestive conditions, and diabetes.
- To evaluate the utility of an immunochemical assay for salivary LF measurement in health screening.
Summary:
- Immunodiffusion assays were employed to quantify lactoferrin (LF) in the mixed saliva of 1,026 patients and 553 healthy controls.
- Significantly elevated salivary LF levels were observed in individuals diagnosed with respiratory diseases, digestive diseases, and diabetes mellitus.
- The findings suggest a correlation between increased salivary LF and the presence of these specific health conditions.
Impact:
- This non-invasive immunochemical assay for salivary lactoferrin (LF) demonstrates potential as a valuable tool for early disease detection.
- The assay could facilitate routine health examinations, enabling effective screening and monitoring of individuals at risk for or diagnosed with certain diseases.
- Implementing this assay may improve patient outcomes through timely identification and management of respiratory and digestive diseases, and diabetes.
Abstract:
Immunodiffusion assays were used to examine lactoferrin (LF) in the mixed saliva of 1026 patients and 553 apparently healthy individuals. Elevated salivary LF levels were found in respiratory and digestive diseases and diabetes. It is concluded that this non-invasive immunochemical assay is promising in the screening and monitoring of persons during their health examination.

